PET/MR in Post Stroke Cardiac Inflammation Study

RecruitingOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

September 2, 2024

Study Completion Date

September 2, 2025

Conditions
StrokeInflammation
Interventions
DIAGNOSTIC_TEST

cardiac PET/MRI

Patients will undergo cardiac PET/MRI scanning at 30±5 days and at 90±5 days post-stroke.

DIAGNOSTIC_TEST

Inflammatory markers

Measurement of a panel of 92 systemic inflammatory markers on patients' blood samples at 30±5 days and at 90±5 days post-stroke

DIAGNOSTIC_TEST

Diagnostic Test: NT-proBNP

NT-proBNP is useful both in the diagnosis and prognosis of heart failure and is considered to be a gold standard biomarker in heart failure. Measurement of NT-proBNP on patients' blood samples at 30±5 days and at 90±5 days post-stroke

Trial Locations (1)

N6A 5A5

RECRUITING

Heart & Brain Lab, Western University, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER